Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Allergic asthma: UFZ researchers identify a key molecule

12.10.2015

Allergies are becoming more commonplace, particularly in industrialised coun-tries. In addition to hay fever, allergic asthma is currently considered to be one of the most widespread allergies. UFZ researchers and their colleagues from the University of Leipzig have recently been successful in finding a protein that plays a critical role in the development of allergic airway inflammation. The discovery could pave the way for new therapies, as it also influences the pro-gression of the allergy.

Worldwide, there are more than 300 million asthma patients. In Germany alone, 10 - 15 percent of children suffer from allergic asthma that is often impaired by environmental pollutants. With the medications available today, symptoms can be effectively relieved, but without tackling the root cause. The precise reasons as to why certain people suffer from allergic asthma are still not fully clear.


It is still not fully clear as to why so many people today suffer from allergic asthma. Researchers from the UFZ and the University of Leipzig have now been successful in discovering a molecule that plays a significant role in the development of allergic asthma.

Photo: Alexander Raths, fotolia

Tobias Polte and his team from the Department of Environmental Immunology at the Helmholtz Centre for Environmental Research (UFZ) collaborated with Jan Simon and his colleagues from the Clinic for Dermatology, Venereology and Allergology at the University of Leipzig and have recently been successful in discovering a molecule that plays a significant role in the development of allergic airway inflammation - as demonstrated in their recent publication in Nature Communications.

The protein syndecan-4 is found in the cell membrane of antigen presenting cells (APCs). These are immune cells that detect exogenous substances (antigens). They internalize them and migrate to the nearest lymph node, where they present them to other immune cells, namely T-cells.

In this way they initiate an immune reaction that leads to sensitization to a particular antigen, like for example to a pollen allergen. It is upon renewed contact with this pollen allergen that the typical symptoms of allergic asthma arise.

"In our study we were able to demonstrate that syndecan-4 plays a critical role in APC migration", says Polte. "When syndecan-4 is lacking, the APCs cannot find their way to the T-cells and consequently cannot activate them. As a result, the immune reaction cannot take place and the sensitization to a particular antigen ceases."

Through investigations at the University of Leipzig, the researchers were also able to show that syndecan-4 in the APCs also plays a central role in the inflammatory process of allergic asthma: the allergic asthma symptoms of mice improved when they were given antibodies against syndecan-4. "In principle, syndecan-4 would be a good starting point for new therapies", says Polte.

"Since it exhibits various other functions in cell metabolism, potential side effects are still difficult to assess." To relieve the symptoms of patients with allergic asthma, the treatment of allergic airway inflammation with glucocorticoids and the use of a bronchodilator asthma spray will continue to be paramount in the near future.

"There will only be an effective therapy that gets to the root cause when we have fully understood the relationships behind the development of allergic asthma", says Polte. "Nevertheless, in our study we were able to discover an important component with syndecan-4 that should help us on the road to identifying new therapies."

Publication:
Polte T, Petzold S, Bertrand J, Schütze N, Hinz D, Simon JC, Lehmann I, Echtermeyer F, Pap T, Averbeck M. Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation Nature Communications 2015 Jul 13;6:7554. http://dx.doi.org/10.1038/ncomms8554
The study was funded by the Helmholtz Community and the Leipzig Research Centre for Civilization Diseases (LIFE).


Contact
Dr. Tobias Polte
Head of the Young Investigators Group LIPAD in the Department of Environmental Immunology Helmholtz Centre for Environmental Research – (UFZ)
phone: +49 341 235 1545
http://www.ufz.de/index.php?de=17308

Prof. Dr. Jan Simon
University Hospital Leipzig (Institution under Public Law) Clinic for Dermatology, Venereology and Allergology
phone: +49 341 97 18603


Contact Media
Susanne Hufe
UFZ press office
Tel. +49 - 341 - 235-1630
www.ufz.de/index.php?en=640


Address
Helmholtz Centre for Environmental Research - UFZ
Permoserstraße 15
04318 Leipzig
Germany
www.ufz.de


In the Helmholtz Centre for Environmental Research (UFZ), scientists conduct research into the causes and consequences of far-reaching environmental changes. Their areas of study cover water resources, biodiversity, the consequences of climate change and possible adaptation strategies, environmental technologies and biotechnologies, bio-energy, the effects of chemicals in the environment and the way they influence health, modelling and social-scientific issues. Its guiding principle: Our research contributes to the sustainable use of natural resources and helps to provide long-term protection for these vital assets in the face of global change. The UFZ employs more than 1,100 staff at its sites in Leipzig, Halle and Magdeburg. It is funded by the federal government, Saxony and Saxony-Anhalt. www.ufz.de


The Helmholtz Association contributes to solving major and urgent issues in society, science and industry through scientific excellence in six research areas: Energy, earth and environment, health, key technologies, structure of matter as well as aviation, aerospace and transportation. The Helmholtz Association is the largest scientific organisation in Germany, with 37,000 employees in 18 research centres and an annual budget of around €4 billion. Its work is carried out in the tradition of the great natural scientist Hermann von Helmholtz (1821-1894). www.helmholtz.de

UFZ Pressestelle | Helmholtz Centre for Environmental Research (UFZ),

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>